FDA Warning Letter Explorer
Drugs · Letter issue date: Oct 26, 2026

Bella’s Nutri Shop Inc.

3 extracted findings

FDA source excerpt, selected passage

On the product label (translated from Chinese): - “Relieve: o Gout o Cholesterol o Stamina o Aches and Pains” - “Uses: Treating Gout, Aches and Pains, Cold, Lower Cholesterol, Boosts Energy and Stamina”

Findings and supporting evidence

Model-assisted readings, not an exhaustive interpretation. Compare with the extracted source findings below.

Findings extracted from the letter

Selected FDA passages, not the complete letter.

01
On the product label (translated from Chinese): - “Relieve: o Gout o Cholesterol o Stamina o Aches and Pains” - “Uses: Treating Gout, Aches and Pains, Cold, Lower Cholesterol, Boosts Energy and Stamina”
02
Based on our review, “Tawon Liar” is an unapproved new drug under section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 355(a).
03
The labeling for “Tawon Liar” does not declare that it contains dexamethasone, tapentadol, or meloxicam.

Sections and clauses cited

As cited in this historical letter, not a statement of current regulatory requirements.

Keep exploring

For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.